A class of anti-cancer drugs that inhibit enzymes called tyrosine kinases. These enzymes are abnormally over-activated in some types of cancer. Inhibiting these tyrosine kinases can increase patient survival by decreasing cancer cell growth and the growth of blood vessels within tumours.